1. Home
  2. SONN vs JFU Comparison

SONN vs JFU Comparison

Compare SONN & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • JFU
  • Stock Information
  • Founded
  • SONN N/A
  • JFU 2006
  • Country
  • SONN United States
  • JFU China
  • Employees
  • SONN N/A
  • JFU N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • JFU Finance: Consumer Services
  • Sector
  • SONN Health Care
  • JFU Finance
  • Exchange
  • SONN Nasdaq
  • JFU Nasdaq
  • Market Cap
  • SONN 21.4M
  • JFU 17.1M
  • IPO Year
  • SONN N/A
  • JFU 2019
  • Fundamental
  • Price
  • SONN $2.85
  • JFU $2.51
  • Analyst Decision
  • SONN Strong Buy
  • JFU
  • Analyst Count
  • SONN 1
  • JFU 0
  • Target Price
  • SONN $20.00
  • JFU N/A
  • AVG Volume (30 Days)
  • SONN 563.6K
  • JFU 27.5K
  • Earning Date
  • SONN 08-13-2025
  • JFU 01-01-0001
  • Dividend Yield
  • SONN N/A
  • JFU N/A
  • EPS Growth
  • SONN N/A
  • JFU N/A
  • EPS
  • SONN N/A
  • JFU 0.58
  • Revenue
  • SONN $1,000,000.00
  • JFU $42,467,427.00
  • Revenue This Year
  • SONN $5,376.22
  • JFU N/A
  • Revenue Next Year
  • SONN N/A
  • JFU N/A
  • P/E Ratio
  • SONN N/A
  • JFU $4.36
  • Revenue Growth
  • SONN 1689.52
  • JFU N/A
  • 52 Week Low
  • SONN $1.08
  • JFU $1.01
  • 52 Week High
  • SONN $19.30
  • JFU $3.60
  • Technical
  • Relative Strength Index (RSI)
  • SONN 39.92
  • JFU 69.35
  • Support Level
  • SONN $3.02
  • JFU $2.31
  • Resistance Level
  • SONN $3.80
  • JFU $3.25
  • Average True Range (ATR)
  • SONN 0.31
  • JFU 0.25
  • MACD
  • SONN -0.04
  • JFU 0.02
  • Stochastic Oscillator
  • SONN 10.26
  • JFU 47.52

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.

Share on Social Networks: